Assessment of Cardiac Dysfunction in Patients With Chronic Obstructive Pulmonary Disease (COPD): A Cross-Sectional Study
- PMID: 37388620
- PMCID: PMC10303266
- DOI: 10.7759/cureus.39629
Assessment of Cardiac Dysfunction in Patients With Chronic Obstructive Pulmonary Disease (COPD): A Cross-Sectional Study
Abstract
Background: Cardiovascular diseases (CVDs) are frequent in patients having chronic obstructive pulmonary disease (COPD). Despite that, comorbid CVDs receive less guideline-recommended screening in this population compared to others. We aimed to evaluate the cardiac function using echocardiography and to assess spirometry, arterial blood gas (ABG) as well as brain natriuretic peptide (BNP) as prognostic indicators of cardiovascular dysfunction in COPD patients.
Methods: One hundred moderate to very severe COPD patients according to GOLD guidelines with no history of cardiac diseases were recruited from two hospitals in Saudi Arabia and evaluated using electrocardiography (ECG), chest X-ray, BNP, pulmonary functions, ABG analysis, and transthoracic echocardiography. Multiple linear regression analysis was used to determine the predictors of right ventricular (RV) and left ventricular (LV) dysfunction.
Results: Pulmonary hypertension (PH) was detected in 28% of the patients, while 25% had abnormal tricuspid annular plane systolic excursion (TAPSE). Low left ventricular ejection fraction (LVEF) and abnormal LV strain were present in 20%, abnormal right ventricular strain was present in 17%, and abnormal fractional area change (FAC) was detected in 9% of patients. Multiple linear regression analysis was used to explore possible determinants of cardiac function. Age, gender, and the presence of diabetes and hyperlipidemia were significant predictors of cardiac dysfunction in COPD patients. Forced vital capacity (FVC) was an independent predictor of LVEF (odds ratio, OR: 0.424, confidence interval, 95 CI%: 0.025-0.505, p<0.031) and FAC (OR: 0.496, 95 CI%: 0.008-655). Hypoxemia and hypercapnia significantly predict both RV and LV dysfunctions. BNP was an independent predictor of FAC (OR: 0.307, 95 CI%: -0.021, p<0.001).
Conclusion: Cardiac abnormalities are common in moderate to very severe COPD patients. Echocardiography could be considered for the assessment of these patients even in the absence of a history of cardiac disease. Pulmonary functions, ABG, and BNP may offer additional predictive information on cardiac functions in COPD patients.
Keywords: abg; bnp; chronic obstructive pulmonary disease; doppler echocardiography; spirometry.
Copyright © 2023, Mohammed et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
ST-Segment Elevation Myocardial Infarction in Patients With Chronic Obstructive Pulmonary Disease: Prognostic Implications of Right Ventricular Systolic Dysfunction as Assessed with Two-Dimensional Speckle-Tracking Echocardiography.J Am Soc Echocardiogr. 2019 Oct;32(10):1277-1285. doi: 10.1016/j.echo.2019.05.016. Epub 2019 Jul 13. J Am Soc Echocardiogr. 2019. PMID: 31311703
-
Effect of Chronic Obstructive Pulmonary Disease (COPD) on Biventricular Mechanics in Patients Without Severe Airflow Obstruction.J Clin Med. 2025 May 23;14(11):3660. doi: 10.3390/jcm14113660. J Clin Med. 2025. PMID: 40507423 Free PMC article. Review.
-
Left ventricular global longitudinal strain in identifying subclinical myocardial dysfunction among patients hospitalized with COVID-19.Int J Cardiol Heart Vasc. 2021 Feb;32:100719. doi: 10.1016/j.ijcha.2021.100719. Epub 2021 Jan 25. Int J Cardiol Heart Vasc. 2021. PMID: 33521240 Free PMC article.
-
Right ventricular function and its coupling to pulmonary circulation predicts exercise tolerance in systolic heart failure.ESC Heart Fail. 2022 Feb;9(1):450-464. doi: 10.1002/ehf2.13726. Epub 2021 Dec 24. ESC Heart Fail. 2022. PMID: 34953062 Free PMC article.
-
Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.Dan Med Bull. 2001 Nov;48(4):199-210. Dan Med Bull. 2001. PMID: 11767125 Review.
References
-
- Chronic obstructive pulmonary disease. Rabe KF, Watz H. Lancet. 2017;389:1931–1940. - PubMed
-
- Chronic obstructive pulmonary disease and cardiac diseases. An urgent need for integrated care. Roversi S, Fabbri LM, Sin DD, Hawkins NM, Agustí A. Am J Respir Crit Care Med. 2016;194:1319–1336. - PubMed
-
- Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial. Vestbo J, Anderson JA, Brook RD, et al. Lancet. 2016;387:1817–1826. - PubMed
-
- Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure. Le Jemtel TH, Padeletti M, Jelic S. J Am Coll Cardiol. 2007;49:171–180. - PubMed
LinkOut - more resources
Full Text Sources